{"parse":{"title":"Pragmatic clinical trial","pageid":54543598,"revid":841436152,"text":{"*":"<div class=\"mw-parser-output\"><p>A <b>pragmatic clinical trial</b> (<b>PCT</b>), sometimes called a <b>practical clinical trial</b> (<b>PCT</b>),<sup id=\"cite_ref-pmid_14506122_1-0\" class=\"reference\"><a href=\"#cite_note-pmid_14506122-1\">&#91;1&#93;</a></sup> is a <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical trial</a> that focuses on <a href=\"/wiki/Correlation_and_dependence\" title=\"Correlation and dependence\">correlation</a> between <a href=\"/wiki/Therapy\" title=\"Therapy\">treatments</a> and <a href=\"/wiki/Outcomes_research\" title=\"Outcomes research\">outcomes</a> in real-world <a href=\"/wiki/Health_system\" title=\"Health system\">health system</a> practice rather than focusing on proving <a href=\"/wiki/Causality\" title=\"Causality\">causative</a> explanations for outcomes, which requires extensive de<a href=\"/wiki/Confounding\" title=\"Confounding\">confounding</a> with <a href=\"/wiki/Inclusion_and_exclusion_criteria\" title=\"Inclusion and exclusion criteria\">inclusion and exclusion criteria</a> so strict that they risk rendering the trial results irrelevant to much of real-world practice.<sup id=\"cite_ref-pmid_20831305_2-0\" class=\"reference\"><a href=\"#cite_note-pmid_20831305-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid_4860352_3-0\" class=\"reference\"><a href=\"#cite_note-pmid_4860352-3\">&#91;3&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Examples\">Examples</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pragmatic_clinical_trial&amp;action=edit&amp;section=1\" title=\"Edit section: Examples\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>A typical example is that an <a href=\"/wiki/Anti-diabetic_medication\" title=\"Anti-diabetic medication\">anti-diabetic medication</a> in the real world will often be used in people with (latent or apparent) <a href=\"/wiki/Diabetic_nephropathy\" title=\"Diabetic nephropathy\">diabetes-induced kidney problems</a>, but if a study of its <a href=\"/wiki/Efficacy\" title=\"Efficacy\">efficacy</a> and <a href=\"/wiki/Adverse_drug_reaction\" title=\"Adverse drug reaction\">safety</a> excluded some subsets of people with kidney problems (to escape confounding), the study's results may not reflect well what will actually happen in broad practice. PCTs thus contrast with explanatory clinical trials,<sup id=\"cite_ref-pmid_4860352_3-1\" class=\"reference\"><a href=\"#cite_note-pmid_4860352-3\">&#91;3&#93;</a></sup> which focus more on causation through deconfounding. The pragmatic versus explanatory distinction is a <a href=\"/wiki/Spectrum\" title=\"Spectrum\">spectrum</a> or <a href=\"/wiki/Continuum_(measurement)\" title=\"Continuum (measurement)\">continuum</a> rather than a <a href=\"/wiki/Dichotomy\" title=\"Dichotomy\">dichotomy</a> (each study can fall toward one end or the other),<sup id=\"cite_ref-pmid_19348971_4-0\" class=\"reference\"><a href=\"#cite_note-pmid_19348971-4\">&#91;4&#93;</a></sup> but the distinction is nonetheless important to <a href=\"/wiki/Evidence-based_medicine\" title=\"Evidence-based medicine\">evidence-based medicine</a> (EBM) because physicians have found that <a href=\"/wiki/Average_treatment_effect\" title=\"Average treatment effect\">treatment effects</a> in explanatory clinical trials do not always translate to outcomes in typical practice. <a href=\"/wiki/Decision-making\" title=\"Decision-making\">Decision-makers</a> (including individual <a href=\"/wiki/Physician\" title=\"Physician\">physicians</a> deciding what to do next for a particular <a href=\"/wiki/Patient\" title=\"Patient\">patient</a>, developers of <a href=\"/wiki/Medical_guideline\" title=\"Medical guideline\">clinical guidelines</a>, and <a href=\"/wiki/Health_policy\" title=\"Health policy\">health policy</a> directors) hope to build a better evidence base to inform decisions by encouraging more PCTs to be conducted.<sup id=\"cite_ref-pmid_14506122_1-1\" class=\"reference\"><a href=\"#cite_note-pmid_14506122-1\">&#91;1&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Distinction_from_other_forms_of_trials\">Distinction from other forms of trials</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pragmatic_clinical_trial&amp;action=edit&amp;section=2\" title=\"Edit section: Distinction from other forms of trials\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The distinction between pragmatic and explanatory trials is not the same as the distinction between <a href=\"/wiki/Randomized_experiment\" title=\"Randomized experiment\">randomized</a> and nonrandomized trials. Any trial can be either randomized or nonrandomized and have any degree of pragmatic and explanatory power, depending on its <a href=\"/wiki/Clinical_study_design\" title=\"Clinical study design\">study design</a>, with randomization being preferable if practicably available. However, most <a href=\"/wiki/Randomized_controlled_trial\" title=\"Randomized controlled trial\">randomized controlled trials</a> (RCTs) to date have leaned toward the explanatory side of the pragmatic-explanatory spectrum, largely because of the value traditionally placed on proving causation by deconfounding as part of proving efficacy, but sometimes also because \"attempts to minimize cost and maximize efficiency have led to smaller sample sizes\".<sup id=\"cite_ref-pmid_20831305_2-1\" class=\"reference\"><a href=\"#cite_note-pmid_20831305-2\">&#91;2&#93;</a></sup> The movement toward supporting <b>pragmatic randomized controlled trials</b> (pRCTs) hopes to make sure that money spent on RCTs is well spent by providing information that actually matters to real-world outcomes,<sup id=\"cite_ref-pmid_20831305_2-2\" class=\"reference\"><a href=\"#cite_note-pmid_20831305-2\">&#91;2&#93;</a></sup> regardless of conclusively tying causation to particular variables. This is the <a href=\"/wiki/Pragmatism\" title=\"Pragmatism\">pragmatic</a> element of such designs. Thus pRCTs are important to <a href=\"/wiki/Comparative_effectiveness_research\" title=\"Comparative effectiveness research\">comparative effectiveness research</a>,<sup id=\"cite_ref-pmid_20831305_2-3\" class=\"reference\"><a href=\"#cite_note-pmid_20831305-2\">&#91;2&#93;</a></sup> and <span id=\"Efficacy_versus_effectiveness\"></span> a distinction is often (although not always) made between <a href=\"/wiki/Efficacy\" title=\"Efficacy\">efficacy</a> and <a href=\"/wiki/Effectiveness\" title=\"Effectiveness\">effectiveness</a>, whereby efficacy implies causation proved by deconfounding other variables (we know with certainty that drug X treats disease Y by mechanism of action Z) but effectiveness implies correlation with outcomes regardless of presence of other variables (we know with certainty that people in a situation similar to X who take drug A tend to have slightly better outcomes than those who take drug B, and even if we think we may suspect why, the causation is not as important).\n</p><p>Explanation remains important, as does traditional efficacy research, because we still value knowledge of causation to advance our understanding of <a href=\"/wiki/Molecular_biology\" title=\"Molecular biology\">molecular biology</a> and to maintain our ability to differentiate real efficacy from <a href=\"/wiki/Placebo\" title=\"Placebo\">placebo effects</a>. What has become apparent in the era of advanced <a href=\"/wiki/Health_technology\" class=\"mw-redirect\" title=\"Health technology\">health technology</a> is that we also need to know about comparative effectiveness in real-world <a href=\"/wiki/Applied_science\" title=\"Applied science\">applications</a> so that we can ensure the best use of our limited resources as we make countless instances of clinical decisions. And it is apparent that explanatory evidence, such as <a href=\"/wiki/In_vitro\" title=\"In vitro\">in vitro</a> evidence and even <a href=\"/wiki/In_vivo\" title=\"In vivo\">in vivo</a> evidence from clinical trials with tight exclusion criteria, often does not help enough, by itself, with that task.<sup id=\"cite_ref-pmid_20831305_2-4\" class=\"reference\"><a href=\"#cite_note-pmid_20831305-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pragmatic_clinical_trial&amp;action=edit&amp;section=3\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-pmid_14506122-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid_14506122_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid_14506122_1-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFTunisStryerClancy2003\" class=\"citation\">Tunis, SR; Stryer, DB; Clancy, CM (2003), \"Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy\", <i>JAMA</i>, <b>290</b> (12): 1624\u20131632, <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.290.12.1624\">10.1001/jama.290.12.1624</a>, <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14506122\">14506122</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Practical+clinical+trials%3A+increasing+the+value+of+clinical+research+for+decision+making+in+clinical+and+health+policy&amp;rft.volume=290&amp;rft.issue=12&amp;rft.pages=1624-1632&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.290.12.1624&amp;rft_id=info%3Apmid%2F14506122&amp;rft.aulast=Tunis&amp;rft.aufirst=SR&amp;rft.au=Stryer%2C+DB&amp;rft.au=Clancy%2C+CM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APragmatic+clinical+trial\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid_20831305-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid_20831305_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid_20831305_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid_20831305_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid_20831305_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid_20831305_2-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFMullinsWhicherReeseTunis2010\" class=\"citation\">Mullins, CD; Whicher, D; Reese, ES; Tunis, S;  et al. (2010), \"Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials\", <i>Pharmacoeconomics</i>, <b>28</b> (10): 969\u2013976, <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2165/11536160-000000000-00000\">10.2165/11536160-000000000-00000</a>, <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20831305\">20831305</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacoeconomics&amp;rft.atitle=Generating+evidence+for+comparative+effectiveness+research+using+more+pragmatic+randomized+controlled+trials&amp;rft.volume=28&amp;rft.issue=10&amp;rft.pages=969-976&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.2165%2F11536160-000000000-00000&amp;rft_id=info%3Apmid%2F20831305&amp;rft.aulast=Mullins&amp;rft.aufirst=CD&amp;rft.au=Whicher%2C+D&amp;rft.au=Reese%2C+ES&amp;rft.au=Tunis%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APragmatic+clinical+trial\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid_4860352-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid_4860352_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid_4860352_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFSchwartzLellouch1967\" class=\"citation\">Schwartz, D; Lellouch, J;  et al. (1967), \"Explanatory and pragmatic attitudes in therapeutical trials\", <i>J Chronic Dis</i>, <b>20</b> (8): 637\u2013648, <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/4860352\">4860352</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Chronic+Dis&amp;rft.atitle=Explanatory+and+pragmatic+attitudes+in+therapeutical+trials&amp;rft.volume=20&amp;rft.issue=8&amp;rft.pages=637-648&amp;rft.date=1967&amp;rft_id=info%3Apmid%2F4860352&amp;rft.aulast=Schwartz&amp;rft.aufirst=D&amp;rft.au=Lellouch%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APragmatic+clinical+trial\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid_19348971-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid_19348971_4-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFThorpe2009\" class=\"citation\">Thorpe, KE;  et al. (2009), \"A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers\", <i>J Clin Epidemiol</i>, <b>62</b> (5): 464\u2013475, <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jclinepi.2008.12.011\">10.1016/j.jclinepi.2008.12.011</a>, <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2679824\">2679824</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>, <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19348971\">19348971</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Epidemiol&amp;rft.atitle=A+pragmatic-explanatory+continuum+indicator+summary+%28PRECIS%29%3A+a+tool+to+help+trial+designers&amp;rft.volume=62&amp;rft.issue=5&amp;rft.pages=464-475&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2679824&amp;rft_id=info%3Apmid%2F19348971&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jclinepi.2008.12.011&amp;rft.aulast=Thorpe&amp;rft.aufirst=KE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APragmatic+clinical+trial\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw2227\nCached time: 20180917222332\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.108 seconds\nReal time usage: 0.129 seconds\nPreprocessor visited node count: 391/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 12803/2097152 bytes\nTemplate argument size: 88/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 7343/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.043/10.000 seconds\nLua memory usage: 2.19 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  104.446      1 -total\n 72.73%   75.968      1 Template:Reflist\n 54.28%   56.694      4 Template:Citation\n 26.39%   27.559      1 Template:Anchor\n  1.85%    1.933      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:54543598-0!canonical and timestamp 20180917222332 and revision id 841436152\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","*":"Clinical_research"}],"links":[{"ns":0,"exists":"","*":"Adverse drug reaction"},{"ns":0,"exists":"","*":"Anti-diabetic medication"},{"ns":0,"exists":"","*":"Applied science"},{"ns":0,"exists":"","*":"Average treatment effect"},{"ns":0,"exists":"","*":"Causality"},{"ns":0,"exists":"","*":"Clinical study design"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Comparative effectiveness research"},{"ns":0,"exists":"","*":"Confounding"},{"ns":0,"exists":"","*":"Continuum (measurement)"},{"ns":0,"exists":"","*":"Correlation and dependence"},{"ns":0,"exists":"","*":"Decision-making"},{"ns":0,"exists":"","*":"Diabetic nephropathy"},{"ns":0,"exists":"","*":"Dichotomy"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Effectiveness"},{"ns":0,"exists":"","*":"Efficacy"},{"ns":0,"exists":"","*":"Evidence-based medicine"},{"ns":0,"exists":"","*":"Health policy"},{"ns":0,"exists":"","*":"Health system"},{"ns":0,"exists":"","*":"Health technology"},{"ns":0,"exists":"","*":"In vitro"},{"ns":0,"exists":"","*":"In vivo"},{"ns":0,"exists":"","*":"Inclusion and exclusion criteria"},{"ns":0,"exists":"","*":"Medical guideline"},{"ns":0,"exists":"","*":"Molecular biology"},{"ns":0,"exists":"","*":"Outcomes research"},{"ns":0,"exists":"","*":"Patient"},{"ns":0,"exists":"","*":"Physician"},{"ns":0,"exists":"","*":"Placebo"},{"ns":0,"exists":"","*":"Pragmatism"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Randomized controlled trial"},{"ns":0,"exists":"","*":"Randomized experiment"},{"ns":0,"exists":"","*":"Spectrum"},{"ns":0,"exists":"","*":"Therapy"}],"templates":[{"ns":10,"exists":"","*":"Template:Anchor"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Citation"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Anchor"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["//doi.org/10.1001/jama.290.12.1624","//www.ncbi.nlm.nih.gov/pubmed/14506122","//doi.org/10.2165/11536160-000000000-00000","//www.ncbi.nlm.nih.gov/pubmed/20831305","//www.ncbi.nlm.nih.gov/pubmed/4860352","//doi.org/10.1016/j.jclinepi.2008.12.011","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2679824","//www.ncbi.nlm.nih.gov/pubmed/19348971"],"sections":[{"toclevel":1,"level":"2","line":"Examples","number":"1","index":"1","fromtitle":"Pragmatic_clinical_trial","byteoffset":1627,"anchor":"Examples"},{"toclevel":1,"level":"2","line":"Distinction from other forms of trials","number":"2","index":"2","fromtitle":"Pragmatic_clinical_trial","byteoffset":3319,"anchor":"Distinction_from_other_forms_of_trials"},{"toclevel":1,"level":"2","line":"References","number":"3","index":"3","fromtitle":"Pragmatic_clinical_trial","byteoffset":6024,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Pragmatic clinical trial","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q48996431"}]}}